S
Sarborg Limited
Founded in 2024, Sarborg Limited integrates proprietary AI agents, mathematical algorithms, and cybernetics to optimize decision-making processes. The company primarily utilizes machine learning and algorithmic strategies to evaluate drug repurposing by matching drug and disease signatures, aiming to improve the probability of success in clinical trials. The company is currently scaling its technology for applications beyond the pharmaceutical sector.
Funding
Every round, secondary, debt facility or acquisition involving Sarborg Limited that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see every AI company on Lounge with revenue, funding, valuation and investors, searchable and sortable, plus CSV exports. Plans start at $19/mo.
See plans →Log in